by Jim Miller and Janet Lowenbach, PharmSource Information Services The EU must harness market forces that reward innovation and competitiveness to combat its current R&D drain.
Janet Lowenbach
Advertisement
Articles by Janet Lowenbach
Advertisement
Latest Updated Articles
- Outsourcing Outlook: Will CROs find opportunity in a Reinvigorated European R&D Sector?
Published: November 15th 2002 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
